A population-based study of sociodemographic and geographic variation in hpv vaccination

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 4, 2017, Pages 533-540

  Rutten, Lila J Finney ^a   Wilson, Patrick M ^a   Jacobson, Debra J ^a   Agunwamba, Amenah A ^a   Breitkopf, Carmen Radecki ^a   Jacobson, Robert M ^a   St Sauver, Jennifer L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AGE; ARTICLE; CHILD; FEMALE; HUMAN; MALE; MINNESOTA; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL STATUS; VACCINATION; ADOLESCENT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; DEMOGRAPHY; SEX FACTOR; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AGE FACTORS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CHILD; DEMOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MINNESOTA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEX FACTORS; SOCIOECONOMIC FACTORS; VACCINATION;

EID: 85016996703     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0877     Document Type: Article

References (32)

1. Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, Mac-Neil J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65:850-8.
2. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014;168: 76-82.
3. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010;171:357-67.
4. Tsui J, Gee GC, Rodriguez HP, Kominski GF, Glenn BA, Singhal R, et al. Exploring the role of neighborhood socio-demographic factors on HPV vaccine initiation among low-income, ethnic minority girls. J Immigr Minor Health 2013;15:732-40.
5. Pruitt SL, Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med 2010;38:525-33.
6. Trogdon JG, Ahn T. Geospatial patterns in human papillomavirus vaccination uptake: evidence from uninsured and publicly insured children in North Carolina. Cancer Epidemiol Biomarkers Prev 2015;24: 595-602.
7. Adjei Boakye E, Tobo BB, Osazuwa-Peters N, Mohammed KA, Geneus CJ, Schootman M. A comparison of parent-and provider-reported human papillomavirus vaccination of adolescents. Am J Prev Med 2016 Nov 24. [Epub ahead of print].
8. Snow J. On the mode of communication of cholera. London, United Kingdom: John Churchill; 1855.
9. Auchincloss AH, Gebreab SY, Mair C, Diez Roux AV. A review of spatial methods in epidemiology, 2000-2010. Annu Rev Public Health 2012; 33:107-22.
10. Krieger N. Historical roots of social epidemiology: socioeconomic gradients in health and contextual analysis. Int J Epidemiol 2001;30:899-900.
11. Roux AVD, Mair C. Neighborhoods and health. Biol Disadv 2010;1186: 125-45.
12. Nelson EJ, Hughes J, Oakes JM, Pankow JS, Kulasingam SL. Geospatial patterns of human papillomavirus vaccine uptake inMinnesota. BMJ Open 2015;5:e008617.
13. Henry KA, StroupAM, Warner EL, Kepka D. Geographic factors and human papillomavirus (HPV) vaccination Initiation among adolescent girls in the United States. Cancer Epidemiol Biomarkers Prev 2016;25:309-17.
14. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
15. Melton LJ III. History of the rochester epidemiology project. Mayo Clin Pro 1996;71:266-74.
16. St. Sauver JL, Grossardt BR, Yawn BP, Meton LJ, Rocca WA. Using a medical records-linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol 2011; 173:1059-68.
17. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:626-9.
18. Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 Years-United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:784-92.
19. Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morb Mortal Wkly Rep 2013;62:591-5.
20. United States Census Bureau. TIGER/Line shapefiles 2014 technical documentation. Available from: https://www2. census. gov/geo/pdfs/mapsdata/ data/tiger/tgrshp2014/TGRSHP2014-TechDoc. pdf/.
21. Lindgren F, Rue H. Bayesian spatial modelling with R-INLA. J Stat Soft 2015;63:1-25.
22. Lindgren F, Rue H, Lindstrom J. An explicit link between Gaussian fields and Gaussian Markov random fields: the SPDE approach (with discussion). J Royal Statist Soc 2011;73:423-98.
23. Rue H, Martino S, Chopin N. Approximate bayesian inference for latent Gaussian models using integrated nested Laplace approximations (with discussion). J Royal Stat Soc 2009;71:319-92.
24. Bolstad WM. Introduction to Bayesian Statistics. Hoboken, NJ: John Wiley & Sons, Inc; 2004.
25. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2007;56:1-24.
26. St Sauver JL, Rutten LJ, Ebbert JO, Jacobson DJ, McGree ME, Jacobson RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med 2016;89:327-33.
27. Block SL, Nolan T, Sattler C, Barr E, Giacoletti KE, Marchant CD, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006;118:2135-45.
28. Giuliano AR, Lazcano-Ponce E, Villa L, Nolan T, Marchant C, Radley D, et al. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. J Infect Dis 2007;196:1153-62.
29. Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J 2007;26:201-9.
30. Institute of Medicine. Capturing social and behavioral domains and measures in electronic health records: phase 2. Washington, DC: The National Academies Press; 2014.
31. Waller LA, Gotway CA. Applied Spatial Statistics for Public Health Data. Hoboken, NJ: John Wiley & Sons, Inc. ; 2004.
32. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 2002;156:471-82.